Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vaxcyte, Inc. - Common Stock
(NQ:
PCVX
)
58.73
-0.99 (-1.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vaxcyte, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Ulta Beauty To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
April 01, 2025
Via
Benzinga
Top stock movements in today's session.
↗
March 31, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
Monday's session: top gainers and losers
↗
March 31, 2025
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
What's Driving the Market Sentiment Around Vaxcyte?
↗
February 25, 2025
Via
Benzinga
Earnings Scheduled For February 25, 2025
↗
February 25, 2025
Via
Benzinga
(PCVX) - Analyzing Vaxcyte's Short Interest
↗
December 16, 2024
Via
Benzinga
(PCVX) - Analyzing Vaxcyte's Short Interest
↗
November 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
March 31, 2025
Via
Benzinga
These stocks are gapping in today's session
↗
March 31, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet
↗
March 31, 2025
Via
Benzinga
Topics
Stocks
Monday's pre-market session: top gainers and losers
↗
March 31, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via
Chartmill
Nasdaq Tumbles Over 300 Points; Chicago PMI Rises In March
↗
March 31, 2025
Via
Benzinga
Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns
↗
March 31, 2025
Peter Marks heads up the department in charge of reviewing vaccines, genetic medicines and cell therapies.
Via
Investor's Business Daily
Vaxcyte Plans To Drop Developing One Pneumococcal Conjugate Vaccine
↗
March 31, 2025
Vaxcyte's VAX-24 Phase 2 trial showed a safety profile similar to PCV20, with strong immune responses and no serious vaccine-related adverse events.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
March 31, 2025
Via
Benzinga
Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study
March 31, 2025
From
Vaxcyte, Inc.
Via
GlobeNewswire
Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study
March 30, 2025
From
Vaxcyte, Inc.
Via
GlobeNewswire
One Vanguard Index Fund to Buy That May Beat the S&P 500 by 100% in the Next Few Years, According to a Wall Street Analyst
↗
March 15, 2025
Via
The Motley Fool
Topics
Stocks
Are Small-Cap Stocks A Buy After Russell 2000 Correction?
↗
March 06, 2025
Investors are questioning the value of small-cap stocks, as reflected by Russell 2000's 15% drop. Some top stocks saw even bigger declines.
Via
Benzinga
Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 25, 2025
From
Vaxcyte, Inc.
Via
GlobeNewswire
Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
February 12, 2025
From
Vaxcyte, Inc.
Via
GlobeNewswire
RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.
↗
February 12, 2025
The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks.
Via
Investor's Business Daily
Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
February 05, 2025
From
Vaxcyte, Inc.
Via
GlobeNewswire
Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference
January 30, 2025
From
Vaxcyte, Inc.
Via
GlobeNewswire
1 Vanguard Index Fund to Buy to Beat the S&P 500 in 2025, According to a Wall Street Bank
↗
December 17, 2024
Via
The Motley Fool
Topics
Stocks
Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
December 03, 2024
From
Vaxcyte, Inc.
Via
GlobeNewswire
1 Vanguard Index Fund May Beat the S&P 500 by 100% in the Next Few Years, According to a Wall Street Analyst
↗
November 20, 2024
Via
The Motley Fool
Topics
Stocks
Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
↗
November 17, 2024
10 worst performing large-cap stocks last week: MPWR, SMCI, MRNA, LDOS, MNDY, PCVX, BAH, ABBV, CACI, XPEV. Check if they're in your portfolio.
Via
Benzinga
Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs
November 12, 2024
From
Vaxcyte, Inc.
Via
GlobeNewswire
Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update
November 05, 2024
From
Vaxcyte, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
